Navigation Links
Volcano Reports 24 Percent Increase in First Quarter Revenues; IVUS Disposable Revenues Increase 30 Percent
Date:5/7/2008

18,058 (1,131) - - 16,927

Operating income 656 1,243 - - 1,899

Interest income 1,195 - - - 1,195

Interest expense (89) - - - (89)

Exchange rate gain 122 - - - 122

Income before

provision for

income taxes 1,884 1,243 - - 3,127

Provision for

income taxes 210 - - - 210

Net income $1,674 $1,243 $- $- $2,917

Net income per

share - basic $0.04 $0.03 $- $- $0.08

Net income per

share - diluted $0.04 $0.03 $- $- $0.07

Weighted-average

shares outstanding -

basic 37,964 37,964

Weighted-average

shares outstanding -

diluted 41,685 41,685

Use of Non-GAAP Financial Measures

This press release includes certain non-GAAP financial information as defined by the U.S. Securities and Exchange Commission Regulation G. Pursuant to the requirements of this regulation, a reconciliation of this non-GAAP financial information to our financial statements as prepared under generally accepted accounting principles in the United States (GAAP) is included in this press release. Non-GAAP financial measures provide an indication of our performance before certain charges. Our management believes that in order to properly understand our short-term and long-term financial trends, investors may wish to consider the impact of these charges. These charges result from facts and circumstances that vary in frequency and/or impact on continuing operations. Our management believes
'/>"/>

SOURCE Volcano Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. Volcano Corporation Presentation at Bear Stearns Conference to be Webcast
2. Volcano Corporation Announces Pricing of Common Stock Offering
3. Volcano Announces Activities at TCT 2007: Expanded Role of IVUS in PCI to be Demonstrated
4. Volcano Announces Closing of CardioSpectra Acquisition
5. Volcano Corporation Schedules Fourth Quarter Conference Call, Webcast
6. Volcano Announces FDA 510(k) Clearance of Revolution Rotational Catheter and FFR for the s5i Integrated IVUS Console
7. Volcano Corporation Presentation at Cowen Healthcare Conference to be Webcast
8. Volcano Announces U.S. and European Launch of Rotational IVUS and Integrated FFR
9. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
10. QMed, Inc. Reports July Medicare SNP Enrollments
11. Phlo Affiliate Reports Expanded Coverage to Oregon Border

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...RNewswire/ -- Reportlinker.com announces that a ne...ogue: ,, Carbondioxide Incubators - A Global M...com/p0164368/Carbondioxide-Incubators---A-Global-M...most critical equipment used in microbiology, gene... providing a controlled environment to grow and st...
(Date:12/2/2009)...swire/ -- The world,s first concept demonstration ...hrough alternative to replace a petrochemically pr...rubber with renewable biomass, made their debut in...on display at a lounge in the common departure are...ut December 21, while the other tire will make app...
(Date:12/2/2009)...cember 2 , - "Bolstering ...itage" , Coinciding with the Internationa... Republic is hosting an international conference i...biological resources in Africa. The,conference wil...isters,scientific experts, private companies, rep...
(Date:12/2/2009)...el, December 2 Gamida Cell announc...nical (animal study) safety and,efficacy of a gene...ill,Cornell Medical College and Gamida Cell. The p...as such as Cooley,s Anemia. , Gamida Cell... ex vivo,populations of stem/progenitor cells. Th...
Breaking Biology Technology:Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 2The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 3Libreville International Conference 2-3 June 2010 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3
...EHOVOT, Israel and JERSEY CITY, New Jersey, Decemb...,innovative molecular diagnostic company leveragin...lidated financial results for the quarter ended,Se...The company recorded revenues for the third quarte...d from the date of acquisition of Parkway Clinical...
...AN DIEGO, Dec. 4 Favrille, Inc.,(OTC Bulletin Boa...a health,information company focused on secure Web...ds (PHRs), announced today that two significant co...ive merger agreement have been met. , (Logo:...F521LOGO ) , "We are pleased to announce tha...
...ORT LAUDERDALE, Fla., Dec. 4 Imaging Diagnostic,S...r in laser optical breast,imaging, announced today...,adjunct to mammography is featured in the Decembe... http://www.newscom.com/cgi-bin/prnh/20040412/IM...ist at Charite Hospital in Berlin,Germany, authore...
Other Biology Technology:Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS 2Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS 3Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS 4Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS 5Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS 6Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS 7Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS 8Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS 9Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS 10Favrille and MyMedicalRecords.com, Inc. Obtain Shareholder Approval to Move Forward With Merger 2Favrille and MyMedicalRecords.com, Inc. Obtain Shareholder Approval to Move Forward With Merger 3Favrille and MyMedicalRecords.com, Inc. Obtain Shareholder Approval to Move Forward With Merger 4Favrille and MyMedicalRecords.com, Inc. Obtain Shareholder Approval to Move Forward With Merger 5Imaging Diagnostic Systems CT Laser Mammography (CTLM) Technology Featured in Peer-Reviewed Journal 2
(Date:12/3/2009)...., Dec. 3 BIO-key Intern... in wireless public safety and finger-based biomet...ority of its shareholders at a Special Shareholder...ny,s Law Enforcement Division to Interact911 Mobil...t in favor and 1.2% were opposed. ,, (Logo: ht...
(Date:12/3/2009)...s or solar panels that repels grime and dirt? Expa...ric car? New Tel Aviv University research, just pu...kthrough in assembling peptides at the nano-scale ...e true in just a few years. , Operating in the r... meter) and even smaller, graduate student Lihi Ad...
(Date:12/3/2009)...Dec. 3, 2009) Van Andel Research Institute (VAR...lant hormone abscisic acid (ABA) works at the mole...l stresses such as drought and cold. Their findin...engineer crops that thrive in harsh environments a... The findings could also have implications for str...
Breaking Biology News(10 mins):BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 2BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 3A window that washes itself? 2VAI researchers find long awaited key to creating drought resistant crops 2VAI researchers find long awaited key to creating drought resistant crops 3Insmed Provides Update on Supply of IPLEX 28TM 29 52763 1Insmed Provides Update on Supply of IPLEX 28TM 29 52763 2Insmed Provides Update on Supply of IPLEX 28TM 29 52763 3Questcor and Child Neurology Foundation Announce Creation of Infantile Spasms Awareness Week 52759 1Questcor and Child Neurology Foundation Announce Creation of Infantile Spasms Awareness Week 52759 2Questcor and Child Neurology Foundation Announce Creation of Infantile Spasms Awareness Week 52759 3Questcor and Child Neurology Foundation Announce Creation of Infantile Spasms Awareness Week 52759 4S C Medical Home Pilot for Diabetes Enrolls 1 110 4781 1S C Medical Home Pilot for Diabetes Enrolls 1 110 4781 2S C Medical Home Pilot for Diabetes Enrolls 1 110 4781 3
...tes and other nations commit to the path of biofue...r sustainable practices in an industry that will, ...Earth,s landscape in a significant way." , In a p...gazine, Melillo and 22 co-authors call for science...stry, which by 2050 could command as much land as ...
...ne for neuroblastoma and melanoma developed by s...edical Center in collaboration with investigators...t impact on tumor growth in mice, according to new...research journal Cancer Immunology, Immunotherapy...uce an immune system response, allowing for a pers...
...er ) show a highly selective behavior towards odor...at a single olfactory stimulus is often not suffic...urces or oviposition sites. Interestingly, the beh...er varieties, so-called "wildtypes". Natural odor...whereas artificial flavors induced a more differen...
Other Biology News:Thinking it through: Scientists call for policy to guide biofuels industry toward sustainability 2Thinking it through: Scientists call for policy to guide biofuels industry toward sustainability 3Children's National researchers develop novel anti-tumor vaccine 2What is wild? Odor attraction among different wildtype Drosophila 2What is wild? Odor attraction among different wildtype Drosophila 3
Bovine Albumin from Bovine Serum, BODIPY FL conjugated/tagged from Molecular Probes (Invitrogen)
Protein Expression Service (Insect cell) from Exon BioSystems
Bovine Albumin from Bovine Serum, Fluorescein conjugated/tagged from Molecular Probes (Invitrogen)
Goat Anti-Human PARAINFLUENZA VIRUS 2+3 Polyclonal Antibody, Unconjugated from AbD Serotec
Biology Products: